THIS TECHNOLOGY COMMERCIALIZATION AGREEMENT made as of the 1st of January, 2004.Technology Commercialization Agreement • May 19th, 2006 • Virexx Medical Corp • Biological products, (no disgnostic substances) • Alberta
WHEREAS the Foundation has approved for Funding the project entitled “A Phase I study of patients with primary or secondary cancers of the liver to determine the safety of Transcatheter Arterial Embolization and Hepclusin Injection” as more particularly described in the Application;
